D&P Bioinnovations

D&P Bioinnovations, LLC, [D&P] is a regenerative medicine company focused on repairing damaged organs with engineered biomaterials and stem cells. The company has developed a platform absorbable immunomodulatory medical device implant to regenerate damaged organs: gastro-intestine, blood vessels, nerves, tendons/ligaments, and muscle. This platform tech addresses the global regenerative medicine market of over $110 billion by the mid 2020s: 1st application to regenerate a damaged esophagus.